There is compelling evidence from the Global Burden of Disease (GBD) Study that the burden of stroke and cardiovascular disease (CVD) has been increasing fast over the last two and half decades. These deficiencies are further highlighted by significant gender and ethnic disparities, and a trend towards more strokes in younger people. This suggests very strongly that currently used primary stroke and CVD prevention measures, which include high-risk (screening of the population for absolute CVD risk) and population-wide strategies, are not sufficiently effective. Identifying the causes of the failure in primary stroke and CVD prevention on individual and population levels and the most promising strategies to improve the situation is the first step in combating these leading causes of disease burden in the world.
There are several important gaps in primary stroke prevention. (1) Lack of awareness: Despite the evidence for modifying health behaviour, 1 the level of public awareness of stroke, its risk factors, and management is low. 2 This means that behaviour modification is suboptimal and can (and should) be greatly enhanced, (2) False reassurance of low risk and lack of motivation: Current primary prevention strategies recommendations primarily target people with moderate to high absolute CVD risk. 3 Individuals labeled as 'low risk' are falsely reassured and not motivated to reduce their risk, despite many having several modifiable risk factors. Indeed, approximately 80% of strokes occur in people categorised as having low absolute risk. 4 Therefore, in communicating absolute CVD risk, categorization of people into low, moderate (mild) and high risk should be abandoned. 5 (3) Management of blood pressure: The current absolute CVD high-risk strategy approach is based on overall CVD risk. Thus, individuals with blood pressures (BP) higher than 140/90 mmHg, which conventionally defines hypertension, may not be treated with antihypertensive medication because of a five-year absolute CVD risk below 15%. 6 However, high BP is an important modifiable risk factor and has been identified as a leading cause of stroke burden worldwide, and therefore should be addressed appropriately. 7 (4) Important stroke risk factors missed from screening: With the exception of smoking, behavioural risk factors such as poor diet, sedentary lifestyle, overweight and excessive alcohol intake are not usually included in the stroke/CVD risk algorithms that are currently used. This is despite the fact that nearly three quarters of the global burden of stroke is linked to lifestyle choices. 7 (5) Low specificity of the CVD prediction algorithms: Most of the currently used CVD prediction algorithms are based on the Framingham study of a primarily white population of North America; therefore, such algorithms may not be applicable to other populations (e.g. Black, Asian, Arabian, Spanish, etc.). (6) Cost barrier in high-risk strategies: Seeing a physician for CVD risk assessment and undertaking laboratory tests required for the risk assessment is a cost barrier for some, hence a low-cost method of risk assessment is needed to address this issue. (7) Lack of effectiveness of high-risk CVD screening: Evidence suggests that even effective population-wide use of high-risk prevention strategies with aggressive pharmacological treatment of high CVD risk individuals would have reduced the incidence of major CVD by, at most, 11%. 8 There is strong evidence from over 240,000 participants in randomized clinical trials 9,10 that just screening for CVD risk has no effect on either incidence or mortality from CVD. (8) Lack of implementation of population-wide strategies: Despite being the most effective, and suggested 30 years ago, 11 there is still no country in the world where populationwide primary prevention strategies have been implemented in full on a country level. Imposing taxes on tobacco, sugar, and alcohol has been suggested as a cost-effective primary stroke/CVD strategy. 5 The resultant revenue from such taxation could further aid the development and implementation of culturally appropriate primary prevention measures and research.
For primary stroke prevention to be effective, the emphasis should be shifted from high-risk prevention to prevention at any level of CVD risk, with the focus on behavioural risk factors; partnering across the health sector, non-government organizations (NGOs) and government bodies; stronger advocacy from NGOs for healthier lifestyles with early life preventative interventions. 5 Stroke/CVD screenings must be accompanied by effective preventative interventions (including population-wide measures) to reduce stroke/CVD risk. 12 In turn, preventative interventions will only be effective if they sufficiently motivate people to reduce their exposure to risk factors and maintain their risk through life at the lowest possible level. 5 Incorporating widely accessible, motivational, educational, affordable and validated mobile technologies for primary prevention (such as the Stroke Riskometer app) into health systems for use by health professionals and lay people offers a promising way to enhance primary stroke/CVD prevention strategies. 5, 13 
